Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'20
Mar'19
Mar'18
Mar'17
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -85.71% vs NA in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -42.86% vs NA in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 25,550.00% vs NA in Mar 2024
Compare Balance Sheet Results of Venmax Drugs
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
5.24
39.86
-34.62
-86.85%
Share Warrants & Outstandings
Total Reserve
-5.90
23.39
-29.29
-125.22%
Shareholder's Funds
4.41
63.26
-58.85
-93.03%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.00
0.00
0.00
0.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.00
0.00
0.00
0.00%
Current Liabilities
Trade Payables
0.63
0.00
0.63
0.00%
Other Current Liabilities
0.08
0.23
-0.15
-65.22%
Short Term Borrowings
0.05
0.00
0.05
0.00%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
0.76
0.23
0.53
230.43%
Total Liabilities
5.17
63.49
-58.32
-91.86%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.04
0.01
0.03
300.00%
Less: Accumulated Depreciation
0.00
0.01
-0.01
-100.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.04
0.00
0.04
0.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
9.15
-9.15
-100.00%
Long Term Loans & Advances
0.00
50.94
-50.94
-100.00%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
0.04
60.09
-60.05
-99.93%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.06
2.89
-2.83
-97.92%
Sundry Debtors
0.95
0.00
0.95
0.00%
Cash and Bank
2.48
0.01
2.47
24,700.00%
Other Current Assets
0.03
0.49
-0.46
-93.88%
Short Term Loans and Advances
1.61
0.00
1.61
0.00%
Total Current Assets
5.13
3.39
1.74
51.33%
Net Current Assets (Including Current Investments)
4.37
3.16
1.21
38.29%
Total Current Assets Excluding Current Investments
5.13
3.39
1.74
51.33%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
5.17
63.49
-58.32
-91.86%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
0.05
0.00
0.05
0.00%
Book Value per share (adjusted)
-1.26
1.59
-2.85
-179.25%
Annual - Borrowings
Borrowings 0.05 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -85.71% vs NA in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Annual - Fixed Assets
Fixed Assets 0.04 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -42.86% vs NA in Mar 2024
Annual - Investments
No Investments in the last few periods
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Annual - Current Assets
Current Assets 5.13 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 25,550.00% vs NA in Mar 2024
